Diabetic nephropathy is now the leading cause of in blood pressure, glycosylated haemoglobin and serum cholesterol following referral. There was a end-stage renal disease in the Western world, and is associated with a higher patient morbidity and significant reduction in the rate of decline of renal function following referral in 39% of patients. With mortality than other causes of renal failure, largely because of associated cardiovascular disease.
Introduction
Diabetic nephropathy is now the leading cause of that of an otherwise matched normal population.6,7 Much of this is due to an excess of cardiovascular end-stage renal disease in patients entering renal replacement programmes in the Western world.1-4 mortality, which is 320 times higher in young diabetics on renal replacement therapy compared with One aim of the WHO St Vincent Declaration is to reduce the incidence of renal failure from diabetic a normal population.8 For patients on renal replacement therapy, hospitalization rates for diabetics are nephropathy by 30%.5 To help achieve this aim, it proposed standards for the management of patients 2-3 times those of other patients,3 and 5-year survival figures are lower (28% vs. 37% for non-diabetics in with established diabetic nephropathy, including vigorous treatment of hypertension (defined as America, and 28% vs. 61% for non-diabetics in Italy1,3. >140/90 mmHg in patients aged <60 years, and >160/90 in patients aged >60 years), dietary This is a study of interventions intended to slow or halt the development of diabetic nephropathy. protein restriction, use of angiotensin-converting enzyme (ACE) inhibitors unless contraindicated, and They inevitably also have the potential to increase the quality and duration of patient's lives, and to referral to a nephrologist when serum creatinine exceeds 200 mmol/l. reduce health care costs. Primary prevention of diabetic nephropathy is the ultimate aim, and interThe development of clinical nephropathy has a significant impact on patient morbidity and mortality.
ventions that may help to achieve this have been reported.9,10 Once overt diabetic nephropathy is In insulin-dependent diabetics with overt diabetic nephropathy, the excess mortality is 70-100 times established, it is more difficult to slow the progression towards end-stage renal failure. Genetic factors may recorded was that measured at the second visit to the renal clinic, in order to avoid the effects of be important in the development and progression of diabetic nephropathy,11,12 and the degree of proanxiety associated with the initial visit. Following referral all patients received specialist teinuria and increasing age at diagnosis13,14 are associated with progression to end stage renal failure. dietetic advice, and were assessed by a renal dietician at regular intervals. They received appropriate Nevertheless, there is some evidence that the natural history of diabetic nephropathy can be altered by individualized advice in order to optimize their intake of protein (0.8-1.0 g/kg body weight/day) fat some therapeutic interventions. Those for which there is most evidence are: effective blood pressure and minerals, to improve diabetic control, control biochemical variables (especially serum potassium control;15-18 use of angiotensin-converting enzyme (ACE) inhibitors;19 and non-dihydropyridine calcium and cholesterol), and to prevent malnutrition. Serial measurements of blood pressure, serum channel blockers;20 dietary protein restriction;21-23 and treatment of dyslipidaemia. 24, 25 Smoking is assocreatinine, serum cholesterol, and glycosylated haemoglobin were recorded at each out-patient visit. ciated with the development and progression of nephropathy.13,26 The role of good glycaemic control These variables were then analysed at intervals of 6 months from referral, to determine whether any once nephropathy is established is less clear, but it is probably beneficial.9,10,27 changes were evident. Any changes in drug therapy were also recorded. The rate of progression of renal This study was undertaken to determine whether referral to a nephrology clinic, where the proposed failure was assessed by measuring the slope of the reciprocal of serum creatinine against time prior to, standards of the St Vincent Declaration and the interventions stated above were applied, slowed the and following, referral to the nephrology clinic. The serum HbA1c assays were performed in two progression of established diabetic nephropathy.
separate laboratories. One laboratory used the customized HPLC system Biomen HAH140 assay throughout the study period. The second laboratory
Methods
used an in-house HPLC system assay until March 1998, then changed to the Biomen HAH140 assay The initial patient cohort comprised 152 consecutive referrals with diabetic nephropathy to a single in line with the first laboratory. The in-house HPLC system assay recorded values of HbA1c at 20% nephrologist during a six-year period (1991) (1992) (1993) (1994) (1995) (1996) (1997) , from a catchment population of 1.5 million. Patients lower than the Biomen HAH140 assay. The earlier values measured in the second laboratory were were excluded from this study if they required renal replacement therapy or died within 6 months of adjusted appropriately to enable comparison of the results. referral (26 patients), if they were referred within the six-month period prior to collation of the data (18 patients), or if there were insufficient data to deterStatistics mine the rate of decline of renal function prior to referral (32 patients) . Therefore data were sub-
The results are presented as means±SEM. The paired sequently analysed from 76 patients.
Student's t-test and the Student's t-test were used for The diagnosis of diabetic nephropathy was made comparison of means where appropriate. The rates on clinical grounds (significant albuminuria of deterioration of renal function were analysed by >300 mg/24 h, or a random urine albumin5creatin-plotting the reciprocal of serum creatinine against ine ratio>20 mg/mmol, diabetic retinopathy, and a time for each patient, and were analysed individually renal ultrasound scan showing near-equal-sized by applying the regression equation: unscarred kidneys). In 22 patients where there had been doubt as to the diagnosis, diabetic nephropathy 1/serum creatinine=a+b1t1+b2t2+e, was confirmed by renal biopsy.
Patients were followed at varying time intervals where t1=time of reading t, for t<0; t1=0 for t>/0, t2=time of reading of t for t>/0; t2=0 for according to their clinical need. Clinics were held in two hospitals. The end point of the study was t<0. a, b1 and b2 are estimated regression coefficients. a is the estimated reciprocal creatinine at defined as the initiation of renal replacement therapy, renal transplantation, or death, whichever was the time=0 (referral date), b1 is the slope of readings before time=0 (prior to referral), and b2 is the slope soonest.
At referral, patient assessment included prescribed of readings after time=0 (post referral). e is the residual (the difference between observed reading medication, smoking history, serum creatinine, blood pressure, serum cholesterol, and glycosylated haemoand estimate from regression equation). The equation was fitted to test the hypothesis H0: b1 does not globin. All data were entered into computerized case records. The initial blood pressure measurement equal b2, which is equivalent to testing whether a regression equation with a common slope b1=b2= ments of serum cholesterol and HbA1c in the patients b would be adequate.
at referral, and 6 and 12 months following referral. The patients' data were analysed to determine
The mean duration of follow-up in these patients whether there was evidence to suggest that b1 did was 689 days (190-2277). ACE inhibitors were not equal b2, and that a two-slope (breakpoint) commenced in 20 patients. At the end of the study model with a break at time 0 was a better fit than a 54 patients (71%) were taking ACE inhibitors. Of the single-slope model-indicating an improvement in 76 patients, 27 (36%) reached end-stage renal failure the rate of deterioration of renal function following during the study and started renal replacement referral (time 0). p values of less than 0.05 were therapy. Ten patients died during the study, five prior considered to indicate significance.
to commencing renal replacement therapy. The rate of decline of renal function was assessed prior to, and following, referral for the 76 patients Results as a whole, and for each individual patient separately, by regression analysis of the plots of reciprocal Referral data on the 76 patients is summarized in serum creatinine against time (as a measure of the Table 1 . Twenty-eight patients had type I diabetes rate of decline of renal function). Analysis of the mellitus, 48 had type II. The mean age for the entire entire group showed that there was a significant group was 58 years (range 29-80). The mean duraslowing in the rate of decline of renal function, tion of diabetes for the group was 18.5 years (range following referral to the nephrology clinic. The mean 5-50). On assessing patients' smoking histories, 18 slope prior to referral was −2.6×10−6, which were current smokers, and 27 were ex-smokers. At changed to −1.5×10−6 following referral ( p= referral, 39 patients (51%) were taking ACE inhibitors.
0.01). Figure 1 illustrates examples of the change in The serial blood pressure measurements at referral, the rate of progression of renal function deterioration and 6 and 12 months following referral, are shown following referral. in Table 2 . Further analysis of measurements beyond Analysis of the results of individual patients 12 months following referral was not appropriate, showed that in 30 patients (39%) there was a due to the small numbers of patients remaining in the study. Table 3 shows the results of serial measuresignificant slowing in the rate of decline of renal function following referral. These 30 patients were appeared to be worse at referral in the group of patients whose rate of decline in renal function further assessed individually to determine whether there had been specific changes in their management improved following referral ('improvers'), compared with those in the other group of patients ('nonfollowing referral that could be associated with the slowing in the rate of decline of renal function.
improvers'). Following referral the improvement in these variables appears greater in the first group than Of these 30 patients, 21 were hypertensive at referral. Following changes to their antihypertensive the second (Figure 2) . However, statistical analysis does not show significant differences in the initial medication (including starting ACE inhibitors in nine), blood pressure improved in 20, and 14 patients variable measurements at referral between the two groups. became normotensive. At referral, nine patients had untreated hypercholesterolaemia (serum cholesterol Regression analysis showed no correlation between the change in slope of reciprocal serum >6.2 mmol/l), which normalized following commencement of statins. At referral four patients were creatinine and the change in mean arterial pressure, serum cholesterol, or serum HbA1c following being prescribed fibrates inappropriately in view of their degree of renal impairment (serum creatinine referral. >300 mmol/l28), and these were subsequently discontinued, with dramatic improvements in their renal function. Following referral, seven patients managed Discussion to stop smoking, and seven patients had an improvement in their diabetic control as judged by HbA1c.
In a previous analysis,29 we presented the results of an audit of the quality of care of these patients with These results are compared in Table 4 with those of the 46 patients in whom there was no improvement diabetic nephropathy at the time of referral to our nephrology clinic. The results showed that care was in the rate of decline in renal function.
Many of the patients had more than one change suboptimal, and that referral was often late. During the course of the present study there was a significant in management that could have contributed to the subsequent improvement in the rate of decline of lowering of blood pressure, and improvement in diabetic control and serum cholesterol. Assessment renal function. However in five patients, apart from attendance at regular out-patient reviews and the of renal function showed that following referral there was a slowing in the rate of decline in renal function specialist dietary advice that they were given, there appeared to be no other active changes in manfor the 76 patients as a whole, and individual patient analysis showed a significant slowing of the rate of agement.
We further compared the management of the 30 deterioration in 30 (39%) patients. Assessment of the change in the rate of progression patients whose rate of decline of renal function slowed following referral with that of the 46 patients of renal failure was made by calculating the gradient of the slope of reciprocal serum creatinine plotted whose renal decline did not improve (Tables 5 and  6 ). There was no significant difference in the degree against time prior to, and following, referral. We accept that this method of determining the change to which blood pressure control or serum cholesterol improved following referral between the two groups, in renal function is not ideal, and has been criticized by other authors, but we feel that it is a realistic but the improvement in diabetic control was greater in the patients whose rate of decline in renal method for auditing routine clinical practice. Following referral, patients were assessed, and function slowed.
On initial inspection, the variables measured individual management plans invoked, including aggressive treatment of hypertension (St Vincent (blood pressure, serum cholesterol, serum HbA1c) Declaration guidelines), and hypercholesterolaemia. relate to their improvement in rate of decline of renal function), statistical analysis found no significNephrotoxic drugs were discontinued, and all patients were regularly reviewed by a renal dietician.
ant difference between the values of variables at referral between the two groups. Of the 30 patients in whom the rate of deterioration slowed significantly, in four patients it was due to
The improvement in rate of renal decline is probably multifactorial. No single factor is identifidiscontinuation of nephrotoxic drugs (fibrates).
On analysis of the patients by dividing them into able in the majority of patients in this study. After referral, all patients were attending clinics more two groups, those in whom the rate of decline in renal function slowed, and those in whom it did not, frequently than they had been before. This increased intensity of care, coupled with the fear instilled in there were no significant changes between the groups in the improvements achieved in management of the patients by having to face the reality of impending renal failure, may simply have encouraged them to blood pressure, serum cholesterol, or diabetic control. Whilst on initial inspection of the results it attend more diligently to the finer points of their care. Bergstrom demonstrated that referral to a speappeared that the variables measured were more poorly controlled at referral in the group who cialist renal clinic can slow the rate of progression of a variety of renal disorders,30,31 and concluded 'improved', and that this group therefore achieved a greater overall change in the variables, (which could that the frequency and quality of clinical check-ups At referral, by use of reciprocal creatinine plots, it was possible to predict the time of need for renal replacement therapies.
